ストックスクリーナーアプリを入手
6.28
0.64%
0.04
アフターアワーズ：
6.44
0.16
+2.55%
Quantum Biopharma Ltd (QNTM) 最新ニュース
Quantum BioPharma adds Kevin Malone as advisor - Investing.com
Quantum Biopharma Announces Advocate Against Naked Short - GlobeNewswire
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin - Bluefield Daily Telegraph
Quantum BioPharma Strengthens Defense: Short Selling Expert Kevin Malone to Combat Market Manipulation - Stock Titan
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Lithium Argentina to Release First Quarter 2025 Results on May 14, 2025 - The Globe and Mail
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Ignore - The Globe and Mail
Quantum BioPharma Secures Legal Victory with $180,000 Award - TipRanks
Quantum BioPharma wins legal battle against former CEO - Investing.com
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario - GlobeNewswire
Latest: Court Upholds $2.8M Award in Quantum BioPharma's Favor Against Former CEO - Stock Titan
2 AI Stocks That Could Help Set You Up for Life - The Globe and Mail
3 ETFs to Save Your Portfolio Right Now - The Globe and Mail
Are These 3 Retail Stocks Oversold or Really in Trouble? - The Globe and Mail
Should You Buy ChargePoint While It's Below $0.70? - The Globe and Mail
BMO Announces Election of Board of Directors - The Globe and Mail
Stocks in play: Bonterra Energy Corp - The Globe and Mail
Time to Load Up on the New Look of SCHD - The Globe and Mail
1 Undervalued Growth Stock You Can Buy During the Stock Market Drop of 2025 - The Globe and Mail
3 Reasons to Avoid SWIM and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Pa - GuruFocus
Quantum BioPharma’s licensee expands retail reach with AATAC deal By Investing.com - Investing.com South Africa
Quantum BioPharma Licensee Celly Nutrition Partners With Asian American Trade Associations Council - marketscreener.com
Quantum BioPharma's licensee expands retail reach with AATAC deal By Investing.com - Investing.com India
Quantum BioPharma's licensee expands retail reach with AATAC deal - Investing.com
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™ - GlobeNewswire
Quantum's Alcohol Detox Drink Lands Massive Deal: Coming to 80,000+ US Stores - Stock Titan
Cathie Wood Snaps Up $30M in Coinbase Stock (COIN) as Tariff Sell-Off Deepens - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Taiwan Semi Stock’s (TSM) Selloff Is ‘Overdone,’ Says BofA - The Globe and Mail
Micro Cap AI Distributor Defies Market Weakness with Record Revenue and Rising Margins - The Globe and Mail
Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Lancaster Colony Stock (LANC) Defies Down Market on Record-Breaking Sales Performance - The Globe and Mail
Why Nvidia, Broadcom, and Taiwan Semiconductor Manufacturing Are Plunging Today - The Globe and Mail
Quantum BioPharma’s ‘unbuzzd’ Launches in Puerto Rico - TipRanks
Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico - The Manila Times
Quantum BioPharma Licensee Celly Nutrition Launches Unbuzzd In Puerto Rico - Barchart.com
3 Best Stocks to Buy Now, 4/3/2025, According to Top Analysts - The Globe and Mail
Quantum BioPharma stock soars on clinical trial success By Investing.com - Investing.com Nigeria
Quantum Biopharma to Jointly Study Demyelination Imaging Technique With Massachusetts Hospital - MarketScreener
Quantum BioPharma in Joint Clinical Study With Massachusetts Hospital to Assess PET Imaging - marketscreener.com
Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis - The Manila Times
Game-Changing MS Detection: Quantum's New PET Technology Could Outperform Traditional MRI - Stock Titan
Quantum BioPharma completes $5 million funding round By Investing.com - Investing.com Canada
Quantum BioPharma completes $5 million funding round - Investing.com
4.83%
1.04%
大文字化:
|
ボリューム (24 時間):